Valuation : Devyser Diagnostics AB

Market Cap 1.01B 106M 91.06M 85.62M 78.21M 146M 10B 147M 393M 5.12B 397M 389M 16.66B P/E 2026 *
99.9x
P/E 2027 * 31.3x
Enterprise Value 965M 101M 86.82M 81.64M 74.57M 139M 9.53B 140M 375M 4.88B 379M 370M 15.88B EV / Sales 2026 *
3.92x
EV / Sales 2027 * 3.27x
Free-Float
70.22%
Yield 2026 *
-
Yield 2027 * -
1 day+0.50%
1 week+1.70%
Current month+2.22%
1 month-8.41%
3 months-37.21%
6 months-33.44%
Current year-47.55%
1 week 58
Extreme 58
60.4
1 month 58
Extreme 58
67.2
Current year 57.8
Extreme 57.8
114.8
1 year 57.8
Extreme 57.8
159.6
3 years 57.4
Extreme 57.4
159.6
5 years 56.1
Extreme 56.1
159.6
10 years 56.1
Extreme 56.1
159.6
Manager TitleAgeSince
Chief Executive Officer 59 04/08/2025
Director of Finance/CFO 43 01/01/2021
Chief Tech/Sci/R&D Officer 48 01/02/2024
Director TitleAgeSince
Chairman 57 27/05/2021
Director/Board Member 49 01/01/2021
Director/Board Member 72 01/01/2021
Date Insider Type Main position Quantity % Market Cap. Importance
25/08/26 Buy

Director

568 0.0034%
11/08/26 Buy

Director

5,000 0.0300%
04/08/26 Buy

Director

250 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%+1.70%-59.96%-17.04% 106M
-2.54%-2.84%-1.90%+14.52% 48.93B
-0.40%+1.03%+439.20%+499.20% 45.01B
-1.42%+2.30%+45.46%+19.36% 44.07B
-1.22%-2.31%+12.40%+71.48% 40.73B
+0.53%-1.36%+16.04%+48.23% 33.52B
-0.21%+9.14% - - 17.77B
-0.35%-1.56%+22.59%+116.19% 16.5B
-1.01%+0.50%+15.83%+27.98% 14.67B
-1.65%-1.03%+77.75%+37.63% 13.77B
Average -0.78%+0.65%+63.05%+90.84% 27.51B
Weighted average by Cap. -1.03%+0.11%+94.80%+122.06%

Financials

2026 *2027 *
Net sales 246M 25.71M 22.14M 20.81M 19.01M 35.56M 2.43B 35.67M 95.49M 1.25B 96.55M 94.45M 4.05B 298M 31.11M 26.78M 25.18M 23M 43.02M 2.94B 43.16M 116M 1.51B 117M 114M 4.9B
Net income 10.07M 1.05M 906K 852K 778K 1.46M 99.45M 1.46M 3.91M 50.97M 3.95M 3.87M 166M 31.97M 3.34M 2.88M 2.71M 2.47M 4.62M 316M 4.64M 12.41M 162M 12.55M 12.28M 526M
Net Debt -47.04M -4.92M -4.23M -3.98M -3.64M -6.8M -465M -6.82M -18.26M -238M -18.47M -18.07M -774M -39M -4.08M -3.51M -3.3M -3.01M -5.64M -385M -5.66M -15.14M -197M -15.31M -14.98M -642M
Logo Devyser Diagnostics AB
Devyser Diagnostics AB is a Sweden-based company engaged in development, manufacture ad sale of kits for genetic testing in routing diagnostic to laboratories. The products are used for complex deoxyribonucleic acid (DNA) testing in the areas of hereditary diseases, oncology, and post-transplantation monitoring in order to diagnose genetic diseases and target cancer treatment. The company has since its inception developed and launched almost 30 products for routine diagnostic use, including Devyser Thrombophilia assay as well as Devyser Resolution XY for analysis of chromosomes X and Y. Devyser Diagnostics’ products are sold directly to the end customer or through hired distributors. The Company provides its products in more than 45 countries.
Employees
110
Date Price Change Volume
04/09/26 SEK 59.90 +0.50% 10,905
03/09/26 SEK 59.60 -0.17% 6,118
02/09/26 SEK 59.70 +2.05% 25,748
01/09/26 SEK 58.50 -0.17% 8,015
31/08/26 SEK 58.60 -0.51% 15,352
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
40.28DKK
Average target price
65.94DKK
Spread / Average Target
+63.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DVYSR Stock